Axol’s proprietary brain stem cells are produced from reprogrammed human blood cells, known as iPS cells, and the new distribution network will manage sales and support in the US, Japan, Scandinavia and several territories in mainland Europe including Germany, Italy and Switzerland.
The move marks a strong statement of intent from the vibrant young business, which is prepared to address a multi-billion dollar global market with its’ significant advantages. Their products eliminate the need for testing human disease pathologies in animal models and they are providing an alternative to researchers who are faced with ethical challenges when considering the use of embryonic stem cells. Neurobiology is one of the major sectors of biomedical research with an annual total public and private funding over $15 billion worldwide.
"Working with such renowned distribution partners provides a great opportunity to introduce the unique advantages of our iPS cells and differentiation technology to the global research markets. We are pleased to partner with such experienced teams, characterized by a history of exceptional customer and technical support", said Naomi Wessel-Carpenter, Marketing Director of Axol.
Axol’s new syndicates include United States Biological with North America coverage and a global reach through 70+ distribution partners. Other leading players in the network are: Cosmo Bio Co. Ltd. in Japan, Caltag Medsystems Ltd. in the UK, LaboSpace S.r.l. (Italy and UK), LuBioScience GmbH (Switzerland), Biozol Diagnostica Vertrieb GmbH, (Germany and Austria) and Bio-Mediator Ky (Finland, Denmark, Sweden and Norway).
When asked about the partnership, Warren Shore, President & CEO of United States Biological commented: "The ready-made, well-characterized stem and functional cells derived from iPS cells provided by Axol nicely complement our portfolio of distributed and internally developed products for life science research markets. Working closely with the Axol team, we will be able to provide our customers with robust, time saving solutions for their discovery and validation projects."
About United States Biological United States Biological is a primary brand for the Life Science Industry offering 350,000+ products. Located in beautiful New England, on Boston's North Shore, an area distinguished for its world-class Universities and Biotech Industry. They are comprised of scientists with decades of experience. They will promptly and thoroughly answer inquiries and enjoy helping to guide researchers through protocols whether for their products or for unique research.
United States Biological's biochemicals, antibodies, recombinant proteins, cells, cell culture media and molecular biology kits are used in virtually all scientific applications and settings, including genomic research, biotechnology, pharmaceutical development and the diagnosis of disease. Products are available from affordable research quantities to larger bulk amounts for process development and production. Their customers include most of the leading pharmaceutical and biotechnology companies located in the US and abroad as well as academic researchers worldwide.
For more information, please visit http://www.usbio.net
Media Contact
Naomi Wessel-Carpenter, Marketing Director, +44(0)1223 497 119 or E n.carpenter@axolbio.com